StockData
Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc. (MBRX) stock

MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$7.87−0.19 (-2.36%)

Close on Nov 13, 2026Market cap $8.23MP/E –Yield –

Moleculin Biotech total assets

Total assets on the balance sheet at the end of each period.

Moleculin Biotech's total assets was $20.74M at Sep 30, 2026. For fiscal 2025 it was $22.13M, up 30.7% from the year before. Over ten years it grew 94.8% a year on average. The highest annual figure on record is $84.09M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$22.13M+30.7%
FY2024Dec 31, 2024$16.93M-55.7%
FY2023Dec 31, 2023$38.22M-33.4%
FY2022Dec 31, 2022$57.42M-31.7%
FY2021Dec 31, 2021$84.09M+189.7%
FY2020Dec 31, 2020$29.03M+15.0%
FY2019Dec 31, 2019$25.24M+28.8%
FY2018Dec 31, 2018$19.59M+0.5%
FY2017Dec 31, 2017$19.48M+18.8%
FY2016Dec 31, 2016$16.39M+58256.8%
FY2015Dec 31, 2015$28.09K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$20.74M+1.9%
Q2 FY2026Jun 30, 2026$21.09M-2.3%
Q1 FY2026Mar 31, 2026$23.36M+11.2%
Q4 FY2025Dec 31, 2025$22.13M+30.7%
Q3 FY2025Sep 30, 2025$20.35M-13.0%
Q2 FY2025Jun 30, 2025$21.59M-15.6%
Q1 FY2025Mar 31, 2025$21.01M-31.9%
Q4 FY2024Dec 31, 2024$16.93M-55.7%
Q3 FY2024Sep 30, 2024$23.39M-40.8%
Q2 FY2024Jun 30, 2024$25.58M-45.7%
Q1 FY2024Mar 31, 2024$30.85M-39.6%
Q4 FY2023Dec 31, 2023$38.22M-33.4%
Q3 FY2023Sep 30, 2023$39.52M-39.5%
Q2 FY2023Jun 30, 2023$47.12M-35.7%
Q1 FY2023Mar 31, 2023$51.06M-35.2%
Q4 FY2022Dec 31, 2022$57.42M-31.7%
Q3 FY2022Sep 30, 2022$65.37M-26.3%
Q2 FY2022Jun 30, 2022$73.26M-21.7%
Q1 FY2022Mar 31, 2022$78.80M-21.0%
Q4 FY2021Dec 31, 2021$84.09M+189.7%
Q3 FY2021Sep 30, 2021$88.70M+226.8%
Q2 FY2021Jun 30, 2021$93.53M+198.1%
Q1 FY2021Mar 31, 2021$99.78M+291.7%
Q4 FY2020Dec 31, 2020$29.03M+15.0%
Q3 FY2020Sep 30, 2020$27.14M-10.7%
Q2 FY2020Jun 30, 2020$31.38M-1.5%
Q1 FY2020Mar 31, 2020$25.47M+19.6%
Q4 FY2019Dec 31, 2019$25.24M+28.8%
Q3 FY2019Sep 30, 2019$30.40M+45.5%
Q2 FY2019Jun 30, 2019$31.85M+32.4%
Q1 FY2019Mar 31, 2019$21.30M-14.6%
Q4 FY2018Dec 31, 2018$19.59M+0.5%
Q3 FY2018Sep 30, 2018$20.90M+1.3%
Q2 FY2018Jun 30, 2018$24.07M+13.3%
Q1 FY2018Mar 31, 2018$24.93M+52.1%
Q4 FY2017Dec 31, 2017$19.48M+10.9%
Q3 FY2017Sep 30, 2017$20.63M–
Q2 FY2017Jun 30, 2017$21.25M–
Q4 FY2016Dec 31, 2016$16.39M–
Q3 FY2016Sep 30, 2016$17.57M–

More Moleculin Biotech figures

See a number that looks wrong?